Search Results - "JUNEAU, P. L"

Refine Results
  1. 1

    Weight bearing as a measure of disease progression and efficacy of anti-inflammatory compounds in a model of monosodium iodoacetate-induced osteoarthritis by Bove, S.E, Calcaterra, S.L, Brooker, R.M, Huber, C.M, Guzman, R.E, Juneau, P.L, Schrier, D.J, Kilgore, K.S

    Published in Osteoarthritis and cartilage (01-11-2003)
    “…Objective: To describe an in vivo model in the rat in which change in weight distribution is used as a measure of disease progression and efficacy of…”
    Get full text
    Journal Article
  2. 2

    Transferrin and iron in normal, Alzheimer's disease, and Parkinson's disease brain regions by Loeffler, D A, Connor, J R, Juneau, P L, Snyder, B S, Kanaley, L, DeMaggio, A J, Nguyen, H, Brickman, C M, LeWitt, P A

    Published in Journal of neurochemistry (01-08-1995)
    “…Oxidant-mediated damage is suspected to be involved in the pathogenesis of several neurodegenerative disorders. Iron promotes conversion of hydrogen peroxide…”
    Get more information
    Journal Article
  3. 3

    Increased regional brain concentrations of ceruloplasmin in neurodegenerative disorders by Loeffler, D.A., LeWitt, P.A., Juneau, P.L., Sima, A.A.F., Nguyen, H.-U., DeMaggio, A.J., Brickman, C.M., Brewer, G.J., Dick, R.D., Troyer, M.D., Kanaley, L.

    Published in Brain research (04-11-1996)
    “…Ceruloplasmin (CP), the major plasma anti-oxidant and copper transport protein, is synthesized in several tissues, including the brain. We compared regional…”
    Get full text
    Journal Article
  4. 4

    Surgically induced osteoarthritis in the rat results in the development of both osteoarthritis-like joint pain and secondary hyperalgesia by Bove, S.E., Laemont, K.D., Brooker, R.M., Osborn, M.N., Sanchez, B.M., Guzman, R.E., Hook, K.E., Juneau, P.L., Connor, J.R., Kilgore, K.S.

    Published in Osteoarthritis and cartilage (01-10-2006)
    “…In the present study, we sought to develop/characterize the pain profile of a rat model of surgically induced osteoarthritis (OA). OA was surgically induced in…”
    Get full text
    Journal Article
  5. 5

    Influence of tumour physico-chemical conditions on interleukin-2-stimulated lymphocyte proliferation by LOEFFLER, D. A, JUNEAU, P. L, MASSERANT, S

    Published in British journal of cancer (01-10-1992)
    “…The proliferative response of murine lymphocytes to interleukin-2 (IL-2) was examined under physico-chemical conditions present in solid tumours, namely low…”
    Get full text
    Journal Article
  6. 6

    Purine-induced alterations of dopamine metabolism in rat pheochromocytoma PC12 cells by Loeffler, D.A, Camp, D.M, Juneau, P.L, Harel, E, LeWitt, P.A

    Published in Brain research bulletin (01-08-2000)
    “…Studies with cerebrospinal fluid from subjects with Parkinson’s disease suggest that purine abnormalities may be present in this disorder. The effects of…”
    Get full text
    Journal Article
  7. 7

    Cerebrospinal Fluid C3a Increases with Age, But Does Not Increase Further in Alzheimer’s Disease by Loeffler, D.A, Brickman, C.M, Juneau, P.L, Perry, M.F, Pomara, N, LeWitt, P.A

    Published in Neurobiology of aging (01-09-1997)
    “…Complement activation is present in the brain in Alzheimer’s disease (AD), and C1q concentrations are decreased in AD cerebrospinal fluid (CSF). To determine…”
    Get full text
    Journal Article
  8. 8

    Time-dependent effects of levodopa on regional brain dopamine metabolism and lipid peroxidation by Loeffler, D.A, LeWitt, P.A, Juneau, P.L, Camp, D.M, Arnold, L.A, Hyland, K

    Published in Brain research bulletin (01-12-1998)
    “…Levodopa treatment in Parkinson’s disease has been suggested to contribute to disease progression through free radical generation. We compared the time course…”
    Get full text
    Journal Article
  9. 9

    Ceruloplasmin is increased in cerebrospinal fluid in Alzheimer's disease but not Parkinson's disease by Loeffler, D A, DeMaggio, A J, Juneau, P L, Brickman, C M, Mashour, G A, Finkelman, J H, Pomara, N, LeWitt, P A

    “…Although the pathophysiology of Alzheimer's disease (AD) and Parkinson's disease (PD) is unknown, altered brain antioxidative mechanisms have been found in…”
    Get more information
    Journal Article
  10. 10

    Effects of enhanced striatal dopamine turnover in vivo on glutathione oxidation by Loeffler, D A, DeMaggio, A J, Juneau, P L, Havaich, M K, LeWitt, P A

    Published in Clinical neuropharmacology (01-08-1994)
    “…In Parkinson's disease (PD), a compensatory increase in dopamine (DA) turnover occurs in the remaining nigrostriatal dopaminergic neurons, resulting in greater…”
    Get more information
    Journal Article
  11. 11

    Altered Guanosine and Guanine Concentrations in Rabbit Striatum Following Increased Dopamine Turnover by Loeffler, D.A, LeWitt, P.A, Juneau, P.L, Camp, D.M, DeMaggio, A.J, Milbury, P, Matson, W.R, Rathbone, M.P

    Published in Brain research bulletin (01-02-1998)
    “…The significance of guanine nucleotides and nucleosides in neurodegenerative disorders is suggested by recent reports that these molecules enhance neurite…”
    Get full text
    Journal Article
  12. 12

    Influence of repeated levodopa administration on rabbit striatal serotonin metabolism, and comparison between striatal and CSF alterations by LOEFFLER, D. A, LEWITT, P. A, JUNEAU, P. L, CAMP, D. M, DEMAGGIO, A. J, HAVAICH, M. K, MILBURY, P. E, MATSON, W. R

    Published in Neurochemical research (01-12-1998)
    “…Parkinson's disease (PD) is characterized by decreased striatal dopamine, but serotonin (5-HT) is also reduced. Because 5-HT decreases following a single…”
    Get full text
    Journal Article
  13. 13

    The novel use of vascular access ports for intravenous self-administration and blood withdrawal studies in squirrel monkeys by Kinsora Jr, J.J, Christoffersen, C.L, Swalec, J.M, Juneau, P.L

    Published in Journal of neuroscience methods (18-07-1997)
    “…An important experimental challenge in research with squirrel monkeys (Saimiri scureus) is the development of a reliable closed intravenous system for long…”
    Get full text
    Journal Article
  14. 14

    Brain extracellular levels of the putative antipsychotic CI-1007 and its effects on striatal and nucleus accumbens dopamine overflow in the awake rat by IYER, R. N, DAVIS, M. D, JUNEAU, P. L, GIORDANI, A. B

    Published in Journal of pharmacy and pharmacology (01-10-1998)
    “…The compound CI-1007 (R-(+)-1,2,3,6-tetrahydro-4-phenyl-1 [(3-phenyl-3-cyclohexen-1-yl)methyl]pyridine maleate) has been identified as a partial dopamine…”
    Get full text
    Journal Article
  15. 15

    Immunocytochemical detection of anti-hippocampal antibodies in Alzheimer's disease and normal cerebrospinal fluid by LOEFFLER, D. A, JUNEAU, P. L, NGUYEN, H.-U, NAJMAN, D, POMARA, N, LEWITT, P. A

    Published in Neurochemical research (01-02-1997)
    “…Immunocytochemical staining was performed to investigate the presence of anti-hippocampal antibodies in cerebrospinal fluid (CSF) from patients with probable…”
    Get full text
    Journal Article
  16. 16

    Effects of the phosphodiesterase inhibitor rolipram on streptococcal cell wall-induced arthritis in rats by Laemont, Keith D, Schaefer, Caralee J, Juneau, Paul L, Schrier, Denis J

    “…The phosphodiesterase-IV (PDE-IV) inhibitor, rolipram, is antiinflammatory in a number of animal models and inhibits the release of a variety of cytokines,…”
    Get full text
    Journal Article
  17. 17

    Markers of dopamine depletion and compensatory response in striatum and cerebrospinal fluid by LOEFFLER, D. A, LEWITT, P. A, DEMAGGIO, A. J, JUNEAU, P. L, MILBURY, P. E, MATSON, W. R

    “…Though depletion of CSF homovanillic acid (HVA) concentration has often been regarded as a direct indicator of dopamine (DA) deficiency in Parkinson's Disease…”
    Get full text
    Journal Article
  18. 18

    Effects of Endothelin-Receptor Antagonism with PD156707 on Myocardial Stunning in Swine by McClanahan, Thomas B, Mertz, Thomas E, Ignasiak, Diane P, Juneau, Paul L, Gallagher, Kim P

    Published in Journal of cardiovascular pharmacology (01-11-1996)
    “…SUMMARYEndothelin (ET) has been proposed to play a role in the pathogenesis of myocardial ischemia/reperfusion injury. The potential role of ET in myocardial…”
    Get full text
    Journal Article
  19. 19
  20. 20

    Natural killer-cell activity under conditions reflective of tumor micro-environment by Loeffler, D A, Juneau, P L, Heppner, G H

    Published in International journal of cancer (30-07-1991)
    “…Natural-killer(NK) activity was examined in the presence of low oxygen tension, low glucose concentration and acidic pH, to determine whether physical…”
    Get more information
    Journal Article